These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36933980)

  • 1. A Risk Model to Predict Statin Non-Adherence Following an Acute Coronary Syndrome.
    Liao YB; Lee M; Poppe KK; Kerr AJ; Stewart RAH
    Heart Lung Circ; 2023 May; 32(5):612-618. PubMed ID: 36933980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What is the Statin Possession Ratio Cut-Off Which Identifies Those at Increased Risk Following Acute Coronary Syndrome (ANZACS-QI 68)?
    Ali M; Kerr AJ; Lee M; Chan DZL
    Heart Lung Circ; 2023 Apr; 32(4):487-496. PubMed ID: 36641263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the 2013 American College of Cardiology/American Heart Association cholesterol guidelines on the prescription of high-intensity statins in patients hospitalized for acute coronary syndrome or stroke.
    Valentino M; Al Danaf J; Panakos A; Ragupathi L; Duffy D; Whellan D
    Am Heart J; 2016 Nov; 181():130-136. PubMed ID: 27823684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of early versus late in-hospital initiation of statin therapy on the clinical outcomes of patients with acute coronary syndrome.
    Li YH; Wu HL; Yang YH; Tsai HS; Chao TH
    Int Heart J; 2007 Nov; 48(6):677-88. PubMed ID: 18160760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between statin treatment and LDL-cholesterol levels on the rate of ST-elevation myocardial infarction among patients with acute coronary syndromes: ACS Israeli Survey (ACSIS) 2002-2010.
    Gottlieb S; Kolker S; Shlomo N; Matetzky S; Leitersdorf E; Segev A; Goldenberg I; Tzivoni D; Weisz G; Moriel M
    Int J Cardiol; 2016 May; 210():133-8. PubMed ID: 26945433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating PCSK9 levels in acute coronary syndrome: Results from the PC-SCA-9 prospective study.
    Cariou B; Guérin P; Le May C; Letocart V; Arnaud L; Guyomarch B; Pichelin M; Probst V
    Diabetes Metab; 2017 Dec; 43(6):529-535. PubMed ID: 28865748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Pharmacist Intervention to Increase Compliance With Guideline-Directed Statin Therapy During an Acute Coronary Syndrome Hospitalization.
    Tunney RK; Johnson DC; Wang L; Cox ZL
    Ann Pharmacother; 2017 May; 51(5):394-400. PubMed ID: 28058865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with Acute Coronary Syndrome are at High Risk Prior to the Event and Lipid Management is Underachieved Pre- and Post- Hospitalization.
    Vlachopoulos C; Andrikopoulos G; Terentes-Printzios D; Tzeis S; Iliodromitis EK; Richter D; Mantas I; Kartalis A; Vasilikos V; Stakos D; Patsilinakos S; Lampropoulos S; Symeonidis D; Kyrpizidis C; Marinakis N; Nikas N; Lekakis J; Tousoulis D; Vardas P
    Curr Vasc Pharmacol; 2018; 16(4):405-413. PubMed ID: 28676022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality rate increases steeply with nonadherence to statin therapy in patients with acute coronary syndrome.
    Allonen J; Nieminen MS; Lokki M; Parkkonen O; Vaara S; Perola M; Hiekkalinna T; Strandberg TE; Sinisalo J
    Clin Cardiol; 2012 Nov; 35(11):E22-7. PubMed ID: 22961648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid Testing, Lipid-Modifying Therapy, and PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Eligibility in 27 979 Patients With Incident Acute Coronary Syndrome.
    Sarak B; Savu A; Kaul P; McAlister FA; Welsh RC; Yan AT; Goodman SG
    Circ Cardiovasc Qual Outcomes; 2021 Apr; 14(4):e006646. PubMed ID: 33813856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-hospital statin initiation characteristics and one-year statin adherence rates in patients hospitalised for acute coronary syndrome.
    Şimşek B; Çınar T; Tanık VO; İnan D; Avcı İİ; Zeren G; Tekkeşin AI; Karabay CY; Gungor B; Tokgozoglu L
    Acta Cardiol; 2021 Oct; 76(8):852-858. PubMed ID: 32677872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between statin adherence level, health care costs, and utilization.
    Zhao Y; Zabriski S; Bertram C
    J Manag Care Spec Pharm; 2014 Jul; 20(7):703-13. PubMed ID: 24967523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demographic differences in the initiation and maintenance of statins in the first year post ACS in New Zealand: a data linkage study (ANZACS-QI 57).
    Muniandy A; Lee M; Grey C; Ferrier K; Kerr AJ
    N Z Med J; 2021 Apr; 134(1534):31-45. PubMed ID: 33927436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure and lipid target adherence in Korean patients receiving angiotensin II receptor blockers/statin regimens.
    Kim HJ; Kim E; Min KB; Min JY
    Curr Med Res Opin; 2017 Feb; 33(2):385-390. PubMed ID: 27819152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term benefits of high-intensity atorvastatin therapy in Chinese acute coronary syndrome patients undergoing percutaneous coronary intervention: A retrospective study.
    Liu H; Dong A; Wang H
    Medicine (Baltimore); 2018 Oct; 97(42):e12687. PubMed ID: 30334951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of lipid profile and effectiveness of management of dyslipidaemia in patients with acute coronary syndromes - Data from the TERCET registry with 19,287 patients.
    Dyrbus K; Gasior M; Desperak P; Nowak J; Osadnik T; Banach M
    Pharmacol Res; 2019 Jan; 139():460-466. PubMed ID: 30527895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance of statin use over 3 years following acute coronary syndromes: a national data linkage study (ANZACS-QI-2).
    Grey C; Jackson R; Wells S; Thornley S; Marshall R; Crengle S; Harrison J; Riddell T; Kerr A
    Heart; 2014 May; 100(10):770-4. PubMed ID: 24436219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fasting triglycerides predict recurrent ischemic events in patients with acute coronary syndrome treated with statins.
    Schwartz GG; Abt M; Bao W; DeMicco D; Kallend D; Miller M; Mundl H; Olsson AG
    J Am Coll Cardiol; 2015 Jun; 65(21):2267-75. PubMed ID: 26022813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A very high prevalence of low HDL cholesterol in Spanish patients with acute coronary syndromes.
    Pintó X; Millán J; Muñoz A; Corbella E; Hernández-Mijares A; Zuñiga M; Mangas A; Pedro-Botet J
    Clin Cardiol; 2010 Jul; 33(7):418-23. PubMed ID: 20641119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins for acute coronary syndrome.
    Vale N; Nordmann AJ; Schwartz GG; de Lemos J; Colivicchi F; den Hartog F; Ostadal P; Macin SM; Liem AH; Mills EJ; Bhatnagar N; Bucher HC; Briel M
    Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD006870. PubMed ID: 25178118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.